Indoco Remedies Ltd.

NSE: INDOCO | BSE: 532612 | ISIN: INE873D01024 | Industry: Pharmaceuticals
| Momentum Trap
326.9000 -5.90 (-1.77%)
NSE Jul 10, 2025 15:41 PM
Volume: 40,761
 

326.90
-1.77%
Prabhudas Lilladhar
IPM is struggling for growth above 10% even after MoM abating COVID concerns and with MRs, physician activities almost reaching pre-COVID level. We believe key reasons for growth below par are (i) subdued new prescription (Rx) leading to volume de-growth (ii) digital marketing yield going south and (iii) sustained lower demand of acute products. Cardiac and anti-diabetic growth takes a breather in Jan-21 at 8.8% and 5.3% after reporting double digit growth in most months during lockdown. While amongst top therapies Gastro and VMN reported double digit growth of 14%...
Indoco Remedies Ltd. has gained 45.68% in the last 3 Months
More from Indoco Remedies Ltd.
Recommended